Cognitive Behavioral Therapy for Sleep Disorders
(CBTi Trial)
Trial Summary
What is the purpose of this trial?
The purpose of this study is to investigate the mechanisms of change in Cognitive Behavioral Therapy for insomnia (CBTi) in a sample of adults aged 50-65. This study aims to evaluate the pre-post treatment change in sleep, circadian rhythms, biomarkers, cognitive performance, and structural and functional magnetic resonance imaging scans (MRI).
Research Team
Daniel J Taylor, Ph.D.
Principal Investigator
The University of Arizona
Eligibility Criteria
Adults aged 50-65 with insomnia, normal cognitive status (MoCA scores ≥24), and access to a computer with video/audio for teletherapy are eligible. They must plan to stay local for 6 months, speak English, have normal hearing, and not start new sleep treatments during the study. Excluded if they have high sleep efficiency (>85%), serious mental health issues, untreated sleep disorders like apnea, current CBTi treatment or circadian rhythm disorders.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete online demographic information, sleep diaries, and undergo a diagnostic in-home sleep study with various assessments
Treatment Phase I
Participants receive up to 12 weeks of insomnia treatment or are placed on a waitlist
12-Week Post-treatment
Participants complete online sleep diaries, actigraphy, and repeat baseline assessments
Treatment Phase II (WLC)
Treatment starts for participants who were on the waitlist
3-Month Follow-Up
Participants complete online self-report questionnaires
Treatment Details
Interventions
- In-Person Cognitive Behavioral Therapy for Insomnia
- Internet Cognitive Behavioral Therapy for Insomnia
- Telehealth Cognitive Behavioral Therapy for Insomnia
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Arizona
Lead Sponsor